Sort
48,018 grants matching “immunotherapy”
Chemo-Immunotherapy in Relapsed/Refactory B-Chronic Lymphocytic Leukemia
$401,851Neil E Kay · Mayo Clinic Rochester · R01 · FY2010 · CA
Mechanisms of Immune Evasion by Hepatitis C Virus
$401,841Andrea L Cox · Johns Hopkins University · R01 · FY2012 · AI
Mechanisms of Immune Evasion by Hepatitis C Virus
$401,841Andrea L Cox · Johns Hopkins University · R01 · FY2011 · AI
BIOBEHAVIORAL INTERVENTIONS FOR ORAL PAIN AND MUCOSITIS
$401,838University Of Pennsylvania · R01 · FY2001 · NR
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$401,814Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2020 · AI
Leveraging Zika virus and the immune system to treat glioblastoma
$401,786Milan Girish Chheda · Washington University · R01 · FY2025 · NS
Targeting metabolic stress to induce pancreatic tumor cell death
$401,714Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
T cell fate decisions and transplant outcomes
$401,666Xian Chang Li · Methodist Hospital Research Institute · R56 · FY2017 · AI
T cell co-stimulation in obesity-induced adipose inflammation
$401,666Tuo Deng · Methodist Hospital Research Institute · R01 · FY2017 · DK
Inter-metastatic divergency in small cell lung cancer; implications for the design of future immunotherapies
$401,624Jose R Conejo-Garcia · Duke University · R01 · FY2023 · CA
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
$401,561Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$401,557University Of Pennsylvania · U10 · FY2000 · CA
Engineering HIV-specific T cells that have improved function and persistence
$401,553E. John Wherry · University Of Pennsylvania · U19 · FY2022 · AI
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
$401,534Yahuan Lou · University Of Texas Hlth Sci Ctr Houston · R01 · FY2014 · DK
The genomic landscape and evolution of cutaneous squamous cell carcinoma
$401,527Alan Hunter Shain · University Of California, San Francisco · R01 · FY2023 · CA
Immune activation by necroptotic cell death
$401,522Andrew Atwell Oberst · University Of Washington · R01 · FY2023 · CA
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$401,513Edgar G. Engleman · Stanford University · U54 · FY2017 · CA
Pathogenesis of Experimental Autoimmune Myocarditis
$401,503David M. Engman · Northwestern University At Chicago · R01 · FY2007 · HL
Engineered Ensemble Nanoimmunotherapies for Cancer
$401,491Rohan Fernandes · George Washington University · R37 · FY2022 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2016 · CA
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
$401,456Aimin Jiang · Roswell Park Cancer Institute Corp · R01 · FY2015 · CA
Mechanisms Used by NKT Cells in the Control of Liver Tumors
$401,449Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The Functional Role and Genetic Control of Invariant HLA-E T Cells in IBD Risk an
$401,435Jonathan Braun · Cedars-Sinai Medical Center · P01 · FY2013 · DK
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
$401,430Craig Lee Slingluff · University Of Virginia · U01 · FY2013 · CA